RSMDF
ResMed Inc. OTC$24.89
Mkt Cap $3.7B
52w Low $16.57
62.8% of range
52w High $29.82
50d MA $24.41
200d MA $24.38
P/E (TTM)
2.6x
EV/EBITDA
19.6x
P/B
0.6x
Debt/Equity
0.1x
ROE
22.9%
P/FCF
22.8x
RSI (14)
—
ATR (14)
—
Beta
0.93
50d MA
$24.41
200d MA
$24.38
Avg Volume
103
About
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation de…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 0.28 | 0.29 | +2.2% | 24.89 | +0.0% | +0.0% | — | — | — | — | — | — |
| Jan 29, 2026 | AMC | 0.27 | 0.28 | +2.3% | 28.00 | +0.0% | +0.0% | +0.0% | +0.0% | +0.4% | +0.4% | +0.9% | — |
| Oct 30, 2025 | AMC | 0.25 | 0.24 | -5.8% | 26.16 | -6.0% | -1.2% | -4.6% | -4.6% | -4.6% | -4.5% | -4.7% | — |
| Apr 23, 2025 | AMC | 0.24 | 0.25 | +4.0% | 30.00 | +0.0% | +0.0% | +0.0% | +0.0% | -26.7% | -26.7% | +0.0% | — |
| Jan 30, 2025 | AMC | 0.23 | 0.23 | +0.9% | 21.70 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +8.3% | — |
| Oct 24, 2024 | AMC | 0.21 | 0.21 | +2.6% | 17.70 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +28.5% | — |
| Aug 1, 2024 | AMC | 0.08 | 0.21 | +160.0% | 17.70 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Apr 25, 2024 | AMC | 0.19 | 0.20 | +5.7% | 17.70 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Jan 24, 2024 | AMC | 0.18 | 0.14 | -20.8% | 16.24 | +16.3% | +13.9% | +18.0% | +18.0% | +18.0% | +18.0% | +17.4% | — |
| Oct 26, 2023 | AMC | 0.16 | 0.15 | -8.1% | 13.89 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +13.9% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15 | Oppenheimer | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| Oct 11 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $14.63 | $14.63 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Sep 28 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $14.76 | $15.19 | +2.9% | +2.9% | +2.9% | +2.9% | +2.9% | -4.7% |
| Sep 17 | BofA Securities | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Sep 12 | Mizuho | Maintains | Buy → Buy | — | $14.76 | $14.76 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Sep 5 | Needham | Upgrade | Hold → Buy | — | $16.57 | $16.57 | +0.0% | +0.0% | +0.0% | -11.2% | -11.2% | -10.9% |
| Sep 4 | UBS | Downgrade | Buy → Neutral | — | — | — | — | — | — | — | — | — |
| Aug 13 | RBC Capital | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| Aug 3 | RBC Capital | Maintains | Outperform → Outperform | — | $22.01 | $22.01 | +0.0% | +0.0% | +0.0% | +0.0% | -18.9% | -18.9% |
| Aug 3 | BofA Securities | Maintains | Buy → Buy | — | $22.01 | $22.01 | +0.0% | +0.0% | +0.0% | +0.0% | -18.9% | -18.9% |
Recent Filings
Data updated apr 28, 2026 7:55pm
· Source: massive.com